213 related articles for article (PubMed ID: 22707614)
1. Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis.
Cisneros J; Hagood J; Checa M; Ortiz-Quintero B; Negreros M; Herrera I; Ramos C; Pardo A; Selman M
Am J Physiol Lung Cell Mol Physiol; 2012 Aug; 303(4):L295-303. PubMed ID: 22707614
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the p14ARF promoter by DNA methylation.
Badal V; Menendez S; Coomber D; Lane DP
Cell Cycle; 2008 Jan; 7(1):112-9. PubMed ID: 18196972
[TBL] [Abstract][Full Text] [Related]
3. Biological significance of promoter hypermethylation of p14/ARF gene: relationships to p53 mutational status in Tunisian population with colorectal carcinoma.
Chaar I; Amara S; Elamine OE; Khiari M; Ounissi D; Khalfallah T; Ben Hmida A; Mzabi S; Bouraoui S
Tumour Biol; 2014 Feb; 35(2):1439-49. PubMed ID: 24065196
[TBL] [Abstract][Full Text] [Related]
4. Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas.
Wang P; Rao J; Yang H; Zhao H; Yang L
J Surg Oncol; 2011 Nov; 104(6):679-84. PubMed ID: 21695702
[TBL] [Abstract][Full Text] [Related]
5. Lung fibroblasts from patients with idiopathic pulmonary fibrosis exhibit genome-wide differences in DNA methylation compared to fibroblasts from nonfibrotic lung.
Huang SK; Scruggs AM; McEachin RC; White ES; Peters-Golden M
PLoS One; 2014; 9(9):e107055. PubMed ID: 25215577
[TBL] [Abstract][Full Text] [Related]
6. Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma.
Zhang C; Guo X; Zhang L; Lu Z; Ma N; Cheng Y; Shen F; Zhang B; Wu M; Wei L
J Surg Oncol; 2008 Nov; 98(6):462-8. PubMed ID: 18683194
[TBL] [Abstract][Full Text] [Related]
7. Association of interindividual differences in p14ARF promoter methylation with single nucleotide polymorphism in primary colorectal cancer.
Kang MY; Lee BB; Ji YI; Jung EH; Chun HK; Song SY; Park SE; Park J; Kim DH
Cancer; 2008 Apr; 112(8):1699-707. PubMed ID: 18327804
[TBL] [Abstract][Full Text] [Related]
8. Correlation between promoter methylation of p14(ARF), TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma.
Xiaofang L; Kun T; Shaoping Y; Zaiqiu W; Hailong S
World J Surg Oncol; 2012 Jan; 10():5. PubMed ID: 22230750
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
[TBL] [Abstract][Full Text] [Related]
10. Nucleolar p14(ARF) overexpression in Reed-Sternberg cells in Hodgkin's lymphoma: absence of p14(ARF)/Hdm2 complexes is associated with expression of alternatively spliced Hdm2 transcripts.
García JF; Villuendas R; Sánchez-Beato M; Sánchez-Aguilera A; Sánchez L; Prieto I; Piris MA
Am J Pathol; 2002 Feb; 160(2):569-78. PubMed ID: 11839577
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.
Sanders YY; Tollefsbol TO; Varisco BM; Hagood JS
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):16-23. PubMed ID: 20724553
[TBL] [Abstract][Full Text] [Related]
12. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
[TBL] [Abstract][Full Text] [Related]
13. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
14. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
[TBL] [Abstract][Full Text] [Related]
15. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis.
Sanders YY; Pardo A; Selman M; Nuovo GJ; Tollefsbol TO; Siegal GP; Hagood JS
Am J Respir Cell Mol Biol; 2008 Nov; 39(5):610-8. PubMed ID: 18556592
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status.
Xiong J; Epstein RJ
Mol Cancer Ther; 2009 Apr; 8(4):779-85. PubMed ID: 19372550
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
18. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
[TBL] [Abstract][Full Text] [Related]
19. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia.
Magdinier F; Wolffe AP
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.
Weihrauch M; Markwarth A; Lehnert G; Wittekind C; Wrbitzky R; Tannapfel A
Hum Pathol; 2002 Sep; 33(9):884-92. PubMed ID: 12378512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
